Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Krystexxa
Pharma
Amgen's products from buyout of Horizon continue to struggle
While Amgen’s legacy products are thriving, those gained from the company’s 2023 buyout of Horizon are struggling, especially blockbuster Tepezza.
Kevin Dunleavy
May 2, 2025 8:18am
Amid buzz for Amgen's obesity drug, company sees revenue boost
May 3, 2024 9:05am
Amgen settles with FTC over its $28B Horizon buyout
Sep 1, 2023 10:03am
Amgen fights FTC's request for injunction against Horizon buyout
Aug 24, 2023 11:12am
Amgen will delay buyout of Horizon, complying with FTC request
May 19, 2023 11:05am
FTC move on Amgen-Horizon doesn't doom Pfizer-Seagen: analysts
May 17, 2023 11:04am
